scispace - formally typeset
Open AccessJournal ArticleDOI

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Reads0
Chats0
TLDR
In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2.
About
This article is published in Cell.The article was published on 2021-04-29 and is currently open access. It has received 1109 citations till now. The article focuses on the topics: Vaccination & Humoral immunity.

read more

Citations
More filters
Journal ArticleDOI

Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review

TL;DR: All concerted efforts in early and accurate diagnosis, education on the COVID-19 virulence, transmission and preventive measures, global vaccination, and therapeutic agents could bring this CO VID-19 pandemic under control across the globe.
Journal ArticleDOI

Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis

TL;DR: In this article , the authors used the Schrodinger docking tool to predict the possible mechanism of the statin group of drugs by which they can inhibit SARS-CoV-2 pathogenesis.
Journal ArticleDOI

Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug

TL;DR: A systematic summary of the structures, immunoregulation, and potential vaccines and targeted drugs of the HCoVs N protein provides insight into the virulence and transmission of SARS-CoV-2 as well as support for further study on epidemic control of COVID-19.
References
More filters
Journal ArticleDOI

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Related Papers (5)